Perspectives on broiler starter feed in China, after one year without AGPs

Antibiotics at therapeutic dosages prevent and treat intestinal diseases in modern broiler industry, whereas antibiotic growth promoters (AGPs), at sub-therapeutic doses in feed, can improve growth performance and gut health of broilers. Since July 1, 2020, when the Chinese government banned AGPs in feed, it has become critical to maintain broiler performance and improve feed conversion rates, especially with the implementation of multi-dimensional caging rearing systems in North China, which results in increased bird density. Other challenges have been the high level of toxins and anti-nutritional factors (ANF) in feed ingredients, causing serious intestinal health problems in chickens. It has now been a year since the Chinese government's ban of AGPs. What is the status of broiler feed formulation in China after this year?
calendar icon 6 July 2021
clock icon 3 minute read
Figure 1. Effect of enzyme-treated soy protein (ESP) on body weight gain of coccidiosis-vaccinated and Clostridium-infected chickens on day 42.
Figure 1. Effect of enzyme-treated soy protein (ESP) on body weight gain of coccidiosis-vaccinated and Clostridium-infected chickens on day 42.
Figure 2. Effect of enzyme-treated soy protein (ESP) on FCR of coccidiosis-vaccinated and Clostridium-infected chickens on day 42.
Figure 2. Effect of enzyme-treated soy protein (ESP) on FCR of coccidiosis-vaccinated and Clostridium-infected chickens on day 42.

Eugene Li

Nutritionist at Hamlet Protein
© 2000 - 2024 - Global Ag Media. All Rights Reserved | No part of this site may be reproduced without permission.